Cargando…
Resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3
Resibufogenin (RB), one of the major active compounds of the traditional Chinese medicine Chansu, has received considerable attention for its potency in cancer therapy. However, the anticancer effects and the underlying mechanisms of RB on pancreatic cancer remain elusive. Here, we found that RB inh...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215888/ https://www.ncbi.nlm.nih.gov/pubmed/30168902 http://dx.doi.org/10.1111/cas.13788 |
_version_ | 1783368228191338496 |
---|---|
author | Liu, Lu Liu, Yang Liu, Xiaojia Zhang, Na Mao, Genxiang Zeng, Qingxuan Yin, Mingxiao Song, Danqing Deng, Hongbin |
author_facet | Liu, Lu Liu, Yang Liu, Xiaojia Zhang, Na Mao, Genxiang Zeng, Qingxuan Yin, Mingxiao Song, Danqing Deng, Hongbin |
author_sort | Liu, Lu |
collection | PubMed |
description | Resibufogenin (RB), one of the major active compounds of the traditional Chinese medicine Chansu, has received considerable attention for its potency in cancer therapy. However, the anticancer effects and the underlying mechanisms of RB on pancreatic cancer remain elusive. Here, we found that RB inhibited the viability and induces caspase‐dependent apoptosis in human pancreatic cancer cells Panc‐1 and Aspc. Resibufogenin‐induced apoptosis was through inhibition of constitutive nuclear factor‐κB (NF‐κB) activity and its target genes’ expression, which was caused by downregulation of transforming growth factor‐β‐activated kinase 1 (TAK1) levels and suppression of IκB kinase activity in Panc‐1 and Aspc cells. This induction of TAK1‐mediated NF‐κB inactivation by RB was associated with increased glycogen synthase kinase‐3 (GSK‐3) phosphorylation and subsequent suppression of its activity. Moreover, RB‐induced GSK‐3 phosphorylation/inactivation acted through activation of protein kinase C but not Akt. Finally, RB suppressed human pancreatic tumor xenograft growth in athymic nude mice. Thus, our findings reveal a novel mechanism by which RB suppresses TAK1‐mediated NF‐κB activity through protein kinase C‐dependent inhibition of GSK‐3. Our findings provide a rationale for the potential application of RB in pancreatic cancer therapy. |
format | Online Article Text |
id | pubmed-6215888 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62158882018-11-08 Resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3 Liu, Lu Liu, Yang Liu, Xiaojia Zhang, Na Mao, Genxiang Zeng, Qingxuan Yin, Mingxiao Song, Danqing Deng, Hongbin Cancer Sci Original Articles Resibufogenin (RB), one of the major active compounds of the traditional Chinese medicine Chansu, has received considerable attention for its potency in cancer therapy. However, the anticancer effects and the underlying mechanisms of RB on pancreatic cancer remain elusive. Here, we found that RB inhibited the viability and induces caspase‐dependent apoptosis in human pancreatic cancer cells Panc‐1 and Aspc. Resibufogenin‐induced apoptosis was through inhibition of constitutive nuclear factor‐κB (NF‐κB) activity and its target genes’ expression, which was caused by downregulation of transforming growth factor‐β‐activated kinase 1 (TAK1) levels and suppression of IκB kinase activity in Panc‐1 and Aspc cells. This induction of TAK1‐mediated NF‐κB inactivation by RB was associated with increased glycogen synthase kinase‐3 (GSK‐3) phosphorylation and subsequent suppression of its activity. Moreover, RB‐induced GSK‐3 phosphorylation/inactivation acted through activation of protein kinase C but not Akt. Finally, RB suppressed human pancreatic tumor xenograft growth in athymic nude mice. Thus, our findings reveal a novel mechanism by which RB suppresses TAK1‐mediated NF‐κB activity through protein kinase C‐dependent inhibition of GSK‐3. Our findings provide a rationale for the potential application of RB in pancreatic cancer therapy. John Wiley and Sons Inc. 2018-09-23 2018-11 /pmc/articles/PMC6215888/ /pubmed/30168902 http://dx.doi.org/10.1111/cas.13788 Text en © 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Liu, Lu Liu, Yang Liu, Xiaojia Zhang, Na Mao, Genxiang Zeng, Qingxuan Yin, Mingxiao Song, Danqing Deng, Hongbin Resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3 |
title | Resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3 |
title_full | Resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3 |
title_fullStr | Resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3 |
title_full_unstemmed | Resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3 |
title_short | Resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3 |
title_sort | resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κb activity through protein kinase c‐dependent inhibition of glycogen synthase kinase 3 |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215888/ https://www.ncbi.nlm.nih.gov/pubmed/30168902 http://dx.doi.org/10.1111/cas.13788 |
work_keys_str_mv | AT liulu resibufogeninsuppressestransforminggrowthfactorbactivatedkinase1mediatednuclearfactorkbactivitythroughproteinkinasecdependentinhibitionofglycogensynthasekinase3 AT liuyang resibufogeninsuppressestransforminggrowthfactorbactivatedkinase1mediatednuclearfactorkbactivitythroughproteinkinasecdependentinhibitionofglycogensynthasekinase3 AT liuxiaojia resibufogeninsuppressestransforminggrowthfactorbactivatedkinase1mediatednuclearfactorkbactivitythroughproteinkinasecdependentinhibitionofglycogensynthasekinase3 AT zhangna resibufogeninsuppressestransforminggrowthfactorbactivatedkinase1mediatednuclearfactorkbactivitythroughproteinkinasecdependentinhibitionofglycogensynthasekinase3 AT maogenxiang resibufogeninsuppressestransforminggrowthfactorbactivatedkinase1mediatednuclearfactorkbactivitythroughproteinkinasecdependentinhibitionofglycogensynthasekinase3 AT zengqingxuan resibufogeninsuppressestransforminggrowthfactorbactivatedkinase1mediatednuclearfactorkbactivitythroughproteinkinasecdependentinhibitionofglycogensynthasekinase3 AT yinmingxiao resibufogeninsuppressestransforminggrowthfactorbactivatedkinase1mediatednuclearfactorkbactivitythroughproteinkinasecdependentinhibitionofglycogensynthasekinase3 AT songdanqing resibufogeninsuppressestransforminggrowthfactorbactivatedkinase1mediatednuclearfactorkbactivitythroughproteinkinasecdependentinhibitionofglycogensynthasekinase3 AT denghongbin resibufogeninsuppressestransforminggrowthfactorbactivatedkinase1mediatednuclearfactorkbactivitythroughproteinkinasecdependentinhibitionofglycogensynthasekinase3 |